PLX ACQUISITION COMPANY, LLC – Trademark Portfolio
Entity Type: 16
PLX ACQUISITION COMPANY, LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include PLX, VAZALORE, PLX PHARMA INC., ASPIRIN MADE AMAZING!, and ASPIRIN THERAPY VAZALORE. The owner is based in BUFFALO, NY.
4455 GENESEE STREET
BUFFALO, NY 14225
Showing of trademarks Trademarks
Trademark Classifications
PLX ACQUISITION COMPANY, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PLX ACQUISITION COMPANY, LLC have?
PLX ACQUISITION COMPANY, LLC has 11 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned.
What trademark classes does PLX ACQUISITION COMPANY, LLC file in?
PLX ACQUISITION COMPANY, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PLX ACQUISITION COMPANY, LLC's most well-known trademarks?
PLX ACQUISITION COMPANY, LLC's registered trademark portfolio includes well-known marks such as PLX, VAZALORE, PLX PHARMA INC., ASPIRIN MADE AMAZING!, and ASPIRIN THERAPY VAZALORE. These are among 10 currently registered trademarks in the portfolio.
What is PLX ACQUISITION COMPANY, LLC's trademark registration success rate?
PLX ACQUISITION COMPANY, LLC has a 91% trademark registration rate, with 10 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.